131 related articles for article (PubMed ID: 36411649)
1. The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of Harakiri and downregulation of XIAP in vitro.
Wilke NL; Abodo LO; Frias C; Frias J; Baas J; Jakupec MA; Keppler BK; Prokop A
Biomed Pharmacother; 2022 Dec; 156():113974. PubMed ID: 36411649
[TBL] [Abstract][Full Text] [Related]
2. KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri.
Kater L; Kater B; Jakupec MA; Keppler BK; Prokop A
J Biol Inorg Chem; 2021 Dec; 26(8):897-907. PubMed ID: 34617137
[TBL] [Abstract][Full Text] [Related]
3. (2,6-Dimethylphenyl)arsonic Acid Induces Apoptosis through the Mitochondrial Pathway, Downregulates XIAP, and Overcomes Multidrug Resistance to Cytostatic Drugs in Leukemia and Lymphoma Cells In Vitro.
Wilke N; Frias C; Berkessel A; Prokop A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731935
[TBL] [Abstract][Full Text] [Related]
4. Calpain-mediated integrin deregulation as a novel mode of action for the anticancer gallium compound KP46.
Jungwirth U; Gojo J; Tuder T; Walko G; Holcmann M; Schöfl T; Nowikovsky K; Wilfinger N; Schoonhoven S; Kowol CR; Lemmens-Gruber R; Heffeter P; Keppler BK; Berger W
Mol Cancer Ther; 2014 Oct; 13(10):2436-49. PubMed ID: 25082959
[TBL] [Abstract][Full Text] [Related]
5. The gallium complex KP46 exerts strong activity against primary explanted melanoma cells and induces apoptosis in melanoma cell lines.
Valiahdi SM; Heffeter P; Jakupec MA; Marculescu R; Berger W; Rappersberger K; Keppler BK
Melanoma Res; 2009 Oct; 19(5):283-93. PubMed ID: 19584767
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Trafficking of the Anticancer Drug Tris(8-Quinolinolato) Gallium (III) (KP46) by Gallium-68/67 PET/SPECT Imaging.
Darwesh AMF; Imberti C; Bartnicka JJ; Al-Salemee F; Blower JE; Rigby A; Bordoloi J; Griffiths A; Ma MT; Blower PJ
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894695
[TBL] [Abstract][Full Text] [Related]
7. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
[TBL] [Abstract][Full Text] [Related]
8. Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition.
Kubista B; Schoefl T; Mayr L; van Schoonhoven S; Heffeter P; Windhager R; Keppler BK; Berger W
J Exp Clin Cancer Res; 2017 Apr; 36(1):52. PubMed ID: 28403890
[TBL] [Abstract][Full Text] [Related]
9. An organometallic analogue of combretastatin A-4 and its apoptosis-inducing effects on lymphoma, leukemia and other tumor cells
Abodo Onambele L; Hoffmann N; Kater L; Hemmersbach L; Neudörfl JM; Sitnikov N; Kater B; Frias C; Schmalz HG; Prokop A
RSC Med Chem; 2022 Sep; 13(9):1044-1051. PubMed ID: 36320328
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein.
Shi Z; Liang YJ; Chen ZS; Wang XH; Ding Y; Chen LM; Fu LW
Oncol Rep; 2007 Apr; 17(4):969-76. PubMed ID: 17342344
[TBL] [Abstract][Full Text] [Related]
11. Gallium Complexes as Anticancer Drugs.
Chitambar CR
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394029
[TBL] [Abstract][Full Text] [Related]
12. Advances in developing tris(8-quinolinolato)gallium(iii) as an anticancer drug: critical appraisal and prospects.
Timerbaev AR
Metallomics; 2009; 1(3):193-8. PubMed ID: 21305117
[TBL] [Abstract][Full Text] [Related]
13. [Fe(III)(salophene)Cl], a potent iron salophene complex overcomes multiple drug resistance in lymphoma and leukemia cells.
Lee SY; Hille A; Kitanovic I; Jesse P; Henze G; Wölfl S; Gust R; Prokop A
Leuk Res; 2011 Mar; 35(3):387-93. PubMed ID: 21131047
[TBL] [Abstract][Full Text] [Related]
14. Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III).
Collery P; Domingo JL; Keppler BK
Anticancer Res; 1996; 16(2):687-91. PubMed ID: 8687115
[TBL] [Abstract][Full Text] [Related]
15. The role of the intrinsic FAS pathway in Titanocene Y apoptosis: The mechanism of overcoming multiple drug resistance in malignant leukemia cells.
Kater L; Claffey J; Hogan M; Jesse P; Kater B; Strauss S; Tacke M; Prokop A
Toxicol In Vitro; 2012 Feb; 26(1):119-24. PubMed ID: 21986259
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a cobalt (III) salen complex that induces apoptosis in Burkitt like lymphoma and leukemia cells, overcoming multidrug resistance in vitro.
Hopff SM; Onambele LA; Brandenburg M; Berkessel A; Prokop A
Bioorg Chem; 2020 Nov; 104():104193. PubMed ID: 32947134
[TBL] [Abstract][Full Text] [Related]
17. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
Ganguly A; Basu S; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Chaudhuri SK
Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205
[TBL] [Abstract][Full Text] [Related]
18. Gallium in cancer treatment.
Jakupec MA; Keppler BK
Curr Top Med Chem; 2004; 4(15):1575-83. PubMed ID: 15579097
[TBL] [Abstract][Full Text] [Related]
19. Novel gold(I) complexes induce apoptosis in leukemia cells via the ROS-induced mitochondrial pathway with an upregulation of Harakiri and overcome multi drug resistances in leukemia and lymphoma cells and sensitize drug resistant tumor cells to apoptosis in vitro.
Ahrweiler-Sawaryn MC; Biswas A; Frias C; Frias J; Wilke NL; Wilke N; Berkessel A; Prokop A
Biomed Pharmacother; 2023 May; 161():114507. PubMed ID: 36958194
[TBL] [Abstract][Full Text] [Related]
20. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
